Stockreport
Will Edwards Lifesciences' (EW) Upgraded 2025–2026 Outlook Reshape Its Long-Term Growth Narrative? [Yahoo! Finance]
Last edwards lifesciences corporation earnings: 4/23 04:15 pm
Check Earnings Report
US:NYSE Investor Relations: ir.edwards.com
Edwards Lifesciences' recent Investor Day outlined upgraded 2025 revenue growth expectations of about 9%–10% and introduced 2026 adjusted EPS guidance of US$2.80–US$2.95, alongside anticipated constant-currency sales growth of 8%–10%.
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | EW | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
EW alerts
EW alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
EW alerts
High impacting Edwards Lifesciences Corporation news events
Weekly update
A roundup of the hottest topics
EW
NEWS
NEWS
- Edwards Lifesciences (NYSE:EW) had its "buy" rating reaffirmed by analysts at Citigroup Inc..[MarketBeat]
- Edwards Lifesciences (NYSE:EW) had its "overweight" rating reaffirmed by analysts at Barclays PLC.[MarketBeat]
- Edwards Lifesciences' Long-term Business Outlook Appears Achievable, RBC Says [Yahoo! Finance][Yahoo! Finance]
- Edwards Lifesciences (NYSE:EW) was given a new $92.00 price target on by analysts at UBS Group AG.[MarketBeat]
- Edwards Lifesciences (NYSE:EW) had its price target raised by analysts at Royal Bank Of Canada from $95.00 to $100.00. They now have an "outperform" rating on the stock.[MarketBeat]
- More
EW
SEC Filings
SEC Filings
- 12/12/25 - Form 4
- 12/12/25 - Form 4
- 12/12/25 - Form 4
- EW's page on the SEC website
- More